BackEvaxion Biotech A/S Overview
Evaxion Biotech A/S - ADR

Evaxion Biotech A/S Discounted Cash Flow

DCF Analysis for EVAX.

Get informed when a big investor buys or sells

+ Follow

Fair Value

$-0.33

Current Fair Value

$-0.33
↓ 109.3% Downside

Overvalued by 109.3% based on the discounted cash flow analysis.

Average Upside/Downside (Comparison Companies)

Loading

Fair Value vs. Stock Price History

Loading

Upside/Downside History

Loading

Upside/Downside Comparison

Loading